郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Control of therapeutic IgG antibodies galactosylation during cultivation process and its impact on IgG1/FcγR interaction and ADCC activity.

期刊：Biologicals : journal of the International Association of Biological Standardization发表年份：2019作者：Vladimir Simonov; Sergey Ivanov; Maxim Smolov; Svetlana Abbasova; Aleksandr Piskunov; Dmitry Poteryaev
阅读更多 →

药效评价Cellular eIF2B subunit localization: implications for the integrated stress response and its control by small molecule drugs.

期刊：Molecular biology of the cell发表年份：2019作者：Rachel E Hodgson; Beatriz A Varanda; Mark P Ashe; K Elizabeth Allen; Susan G Campbell
阅读更多 →

药效评价In-Use Stability of the Rituximab Biosimilar CT-P10 (Truxima®) Following Preparation for Intravenous Infusion and Storage.

期刊：BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy发表年份：2019作者：Su Jung Kim; Kwang Woo Kim; Yeon Kyeong Shin; Ji Woong Kwon; Hye Young Kang; Yoon A Park; Ji Young Shin; So Young Kim; Won Yong Han
阅读更多 →

药效评价Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.

期刊：Current Alzheimer research发表年份：2019作者：Martina Kaniakova; Eugenie Nepovimova; Lenka Kleteckova; Kristyna Skrenkova; Kristina Holubova; Zofia Chrienova; Vendula Hepnarova; Tomas Kucera; Tereza Kobrlova; Karel Vales; Jan Korabecny; Ondrej Soukup; Martin Horak
阅读更多 →